Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.

MLA

Quaglino, P., et al. “Treatment of Early-Stage Mycosis Fungoides: Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study.” The British Journal of Dermatology, vol. 184, no. 4, Apr. 2021, pp. 722–30. EBSCOhost, https://doi.org/10.1111/bjd.19252.

APA

Quaglino, P., Prince, H. M., Cowan, R., Vermeer, M., Papadavid, E., Bagot, M., Servitjie, O., Berti, E., Guenova, E., Stadler, R., Querfeld, C., Busschots, A. M., Hodak, E., Patsatsi, A., Sanches, J., Maule, M., Yoo, J., Kevin, M., Fava, P., … Scarisbrick, J. J. (2021). Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. The British Journal of Dermatology, 184(4), 722–730. https://doi.org/10.1111/bjd.19252

Chicago

Quaglino, P, H M Prince, R Cowan, M Vermeer, E Papadavid, M Bagot, O Servitjie, et al. 2021. “Treatment of Early-Stage Mycosis Fungoides: Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study.” The British Journal of Dermatology 184 (4): 722–30. doi:10.1111/bjd.19252.